Member States should be able to take action in case of non-compliance with good manufacturing practice for investigational medicinal products for human use.
Recital 14, Regulation (EU) 2017/1569
In forcesince 23 May 2017
Member States should be able to take action in case of non-compliance with good manufacturing practice for investigational medicinal products for human use.